Resource Center: screening and diagnosis, assessment

From Treatment Improvement Protocol (TIP) Series from SAMHSA, published in 2012. Title implies this is related to chronic opioid therapy for patients in recovery from substance use disorders, which it is, but it also is relevant to use of chronic opioid therapy for all patients and preventing substance use disorders.

A comprehensive PDF from CSAM that contains 1) the Drug Abuse Screening Test (DAST-10), 2) the Skinner Trauma History, 3) the CAGE questionnaire, 4) the TWEAK questionnaire, 5) the Alcohol Use Disorder Identification Test (AUDIT), 6) the Michigan Alcoholism Screening Test (MAST), 7) the Self-Administered Short Michigan Alcoholism Screening Test (SMAST), 8) Narcotic Withdrawal Scale, 9) the Clinical Institute Narcotic Assessment (CINA) Scale for Withdrawal, 10) the Clinical Opiate Withdrawal Scale (COWS), 11) the Objective Opiate Withdrawal Scale (OOWS), 12) the Subjective Opiate Withdrawal Scale (SOWS), and 13) the Addiction Research Foundation Clinical Institute for Withdrawal Assessment (CIWA-Ar). (From Their Website)

The 10-question Alcohol Use Disorders Identification Test (AUDIT) was developed by the World Health Organization (WHO) specifically for primary care settings as a screen for detecting at-risk or hazardous drinking. A shorter version of the AUDIT also is used in primary care and consists of the first 3 questions of the AUDIT.

The Michigan Alcoholism Screening Test (MAST) is a 25-item questionnaire used to screen for alcohol abuse and dependence.

Printable PDF version of the AUDIT substance abuse screening tool (reprinted with permission from the WHO.) The purpose of AUDIT is to assess hazardous and harmful alcohol consumption within the past year. The target population is adults. It can be administered by patient interview or self report.

Symptoms, Red Flags, and Risk Factors of Abuse/Dependence informational page

This manual has been prepared by the Drug Enforcement Administration, Office of Diversion Control, to assist practitioners (physicians, dentists, veterinarians, and other registrants authorized to prescribe, dispense, and administer controlled substances) in their understanding of the Federal Controlled Substances Act and its implementing regulations as they pertain to the practitioner’s profession.

The mood disorder questionnaire consists of five yes or no questions to be completed by the patient. The MDQ was developed by a team of psychiatrists, researchers and consumer advocates to address a critical need for timely and accurate diagnosis of bipolar disorder, which can be fatal if left untreated. The questionnaire takes about five minutes to complete, and can provide important insights into diagnosis and treatment.

A site for physicians, researchers, pharmacists, nurses, and counselors to learn more about buprenorphine as a medication for opioid addiction treatment.

This National Institute on Drug Abuse monograph includes helpful information on screening and assessment.